Diabetes and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms-What do We Know?

Journal of Urology

Volumn 182, Issue 6 SUPPL., 2009, Pages

  Sarma, Aruna V ^b   Parsons, J Kellogg ^c   McVary, Kevin ^d   Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Rady Children's Specialists of San Diego   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

aging; diabetes mellitus; prostatic hyperplasia; urinary tract; urination disorders

Indexed keywords

AGING; ARTICLE; CLINICAL RESEARCH; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPOTHESIS; LOWER URINARY TRACT SYMPTOM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK FACTOR;

AGE FACTORS; DIABETES MELLITUS; HUMANS; MALE; PREVALENCE; PROSTATIC HYPERPLASIA; RISK FACTORS; URINATION DISORDERS;

EID: 71849115225     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.088     Document Type: Article

References (31)

1. Wei J.T., Calhoun E., and Jacobsen S.J. Urologic Diseases in America Project: benign prostatic hyperplasia. J Urol 173 (2005) 1256
2. Sarma A.V., and Parsons J.K. Diabetes and benign prostatic hyperplasia: emerging clinical connections. Curr Urol Rep 10 (2009) 4
3. Berry S.J., Coffey D.S., Walsh P.C., et al. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474
4. Rohrmann S., Smit E., Giovannucci E., et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obesity 29 (2005) 310
5. Sasaki K., Yoshimura N., and Chancellor M.B. Implications of diabetes mellitus in urology. Urol Clin North Am 30 (2003) 1
6. Frimodt-Moller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med 92 (1980) 318
7. Kaplan S.E., Te A.E., and Blaivas J.G. Urodynamic findings in patients with diabetic cystopathy. J Urol 153 (1995) 342
8. Sarma A.V., Burke J.P., Jacobson D.J., et al. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care 31 (2008) 476
9. Michel M.C., Mehlburger L., Schumacher H., et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 163 (2000) 1725
10. Parsons J.K., Carter H.B., Partin A.W., et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91 (2006) 2562
11. Hammarsten J., and Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 39 (2001) 151
12. Hammarsten J., and Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 8 (1999) 29
13. Hammarsten J., Hogstedt B., Holthuis N., et al. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1 (1998) 157
14. Nandeesha H., Koner B.C., Dorairajan L.N., et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta 370 (2006) 89
15. Parsons J.K., Bergstrom J., and Barrett-Connor E. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int 101 (2008) 313
16. Boon T.A., Van Venrooij G.E., and Eckhardt M.D. Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia. Curr Urol Rep 2 (2001) 297
17. Kristal A.R., Arnold K.B., Schenk J.M., et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177 (2007) 1395
18. Burke J.P., Jacobson D.J., McGree M., et al. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota. Urology 67 (2006) 22
19. Chokkalingam A.P., Gao Y.T., Deng J., et al. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 52 (2002) 98
20. Glynn R.J., Campion E.W., Bouchard G.R., et al. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 121 (1985) 78
21. Sidney S., Quesenberry Jr. C., Sadler M.C., et al. Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 38 (1991) 13
22. Meigs J.B., Mohr B., Barry M.J., et al. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935
23. Van Den Eeden S.K., Enger S., Caan B.L., et al. Urologic conditions and diabetes in the California Men's Health Study. Urologic Complications of Diabetes (2003), National Institutes of Health, Bethesda 49 abstract
24. Brown J.S., Wessells H., Chancellor M.B., et al. Urologic complications of diabetes. Diabetes Care 28 (2005) 177
25. Rohrmann S., Platz E.A., and Giovannucci E. Lifestyle and benign prostatic hyperplasia in older men: what do we know?. J Men's Health Gender 2 (2005) 230
26. McVary K.T., Rademaker A., Lloyd G.L., et al. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 174 (2005) 1327
27. Cohen P., Peehl D.M., and Rosenfeld R.G. The IGF axis in the prostate. Horm Metab Res 26 (1994) 81
28. Sarma A.V., Jaffe C.A., Schottenfeld D., et al. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among black men. Urology 59 (2002) 362
29. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752
30. Kramer G., Mitteregger D., and Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?. Eur Urol 51 (2007) 1202
31. Sciarra A., Di S.F., Salciccia S., et al. Inflammation and chronic prostatic diseases: evidence for a link?. Eur Urol 52 (2007) 964